IFF INTERNATIONAL FLAVORS & FRAGRANCES INC

BULLISH Impact: 4/10 ANALYST-UPGRADE
Processed 29d 16h ago SEC analyst-IFF-oppenhei-20260213
11 firms acted on IFF: Oppenheimer, Wolfe Research, Tigress Financial, Barclays, Argus Research, Morgan Stanley, Vertical Research, Mizuho, Stifel, Oppenheimer, Morgan Stanley
Final — all horizons settled through T+60d
IFF ▼ -4.90% at T+60d
LONG call ✗ call lost -4.90% · α vs SPY -13.46% · entry $82.51 → $78.47
Last close $78.27 (close Jun 12) · -5.14% from $82.51 entry
Entry anchored
Feb 13, 09:57 AM ET
via Databento tick
T+1d
-0.31%
call -0.31% · α -0.47%
$82.25
settled 4mo ago
T+5d
-0.92%
call -0.92% · α -1.01%
$81.76
settled 4mo ago
T+20d
-15.55%
call -15.55% · α -13.96%
$69.68
settled 3mo ago
T+60d
-4.90%
call -4.90% · α -13.46%
$78.47
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Oppenheimer upgraded International Flavors & Fragrances (IFF) from Perform to Outperform on February 13, setting a $97 price target. The call is part of a cluster of 11 firms acting on IFF simultaneously, including Barclays, Mizuho, and Morgan Stanley. Oppenheimer's track record is below average at 40% accuracy on 5 calls with a -3.9% average return. Consensus stands overwhelmingly bullish: 76% Buy/Strong Buy (19 of 25 analysts), 24% Hold, and zero Sell. The mean PT is $91.58, median $92, with a high of $105 and low of $71. At $76.79, IFF trades at a 19% discount to the mean target. Momentum is mixed — near-term EPS estimates have been revised down (9 cuts vs 1 raise over 30 days for the current quarter), but full-year FY0 and FY1 estimates are being raised (10 and 12 upgrades vs 3 downgrades). Insider buying is a standout signal: CEO Fyrwald and Chairman Fribourg purchased ~$2M combined in March, strongly aligned with the upgrade. Short interest is an extreme 58% of float. Institutional flows are split — Norges Bank opened a $113M position while Renaissance exited. Bottom line: the analyst cluster and insider buying converge bullishly amid extreme shorts, creating a potential squeeze narrative.

Impact Score

Base Score
3/7
LLM Adjustment
+1
Final Score
4/10

Consensus & Targets

Buy / Strong Buy
19 (76%)
Hold
6
Sell / Strong Sell
0
Total Analysts
17
Mean PT
$91.58
Median PT
$92.00
High PT
$105.00
Low PT
$71.00
Current Price
$76.79
Implied Upside
+19.3%

Consensus is heavily bullish: 7 Strong Buy, 12 Buy, 6 Hold, 0 Sell, and 0 Strong Sell across 25 analysts. That equates to 76% Buy/Strong Buy and 24% Hold, with no bearish voices. The consensus direction is clearly positive.

The current price of $76.79 implies 19.3% upside to the mean PT of $91.58. The median PT is $92, the high is $105, and the low is $71. Oppenheimer's $97 target sits above the mean and median, in the upper third of the range.

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-05-08 Barclays maintain Overweight $90.00
2026-05-07 Citigroup maintain Buy $96.00
2026-05-07 JP Morgan maintain Overweight $92.00
2026-05-07 Oppenheimer maintain Outperform $90.00
2026-04-22 Oppenheimer maintain Outperform $88.00
2026-04-14 Barclays maintain Overweight $80.00
2026-04-13 Citigroup maintain Buy $90.00
2026-04-09 UBS maintain Neutral $75.00
2026-02-17 Barclays maintain Overweight $91.00
2026-02-17 Mizuho maintain Outperform $92.00

Over the past 30 days, there have been 0 upgrades and 0 downgrades in analyst ratings. EPS revision trends are mixed: current-quarter estimates have been cut 9 times vs 1 raise, and next-quarter estimates similarly cut 9 vs 1 raise. However, full-year FY0 and FY1 estimates have been revised up 10 and 12 times vs 3 downgrades each, indicating near-term caution but long-term optimism.

Firm Track Record — Oppenheimer

Oppenheimer accuracy: 52% on 1809 calls | avg return: 3.6%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 13 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
Mizuho 75% 3/4 0% top tier
Stifel 60% 3/5 -1.9% above average
Citigroup 57% 4/7 3.5% above average
Morgan Stanley 57% 4/7 2.9% above average
Argus Research 50% 1/2 -1.5% below average
Tigress Financial 50% 1/2 -4.8% below average
Oppenheimer 40% 2/5 -3.9% below average
UBS 38% 3/8 0.5% below average
B of A Securities 33% 1/3 3.9% below average
Wells Fargo 33% 2/6 1.6% below average

Oppenheimer has a 40% accuracy rate on 5 rated calls with an average return of -3.9%, placing it below average among covering firms. The best-performing firm is Mizuho (75% on 4 calls, 0% avg return), followed by Stifel (60% on 5, -1.9%). The worst are JP Morgan and Baird, both at 0% accuracy (5 and 2 calls respectively).

Earnings Estimates

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
0q $1.12 $1.05 — $1.14 $2.7B ↑2 ↓0
+1q $1.14 $1.07 — $1.23 $2.7B ↑3 ↓0
+1y $4.87 $4.50 — $5.42 $11.1B ↑12 ↓0
0y $4.48 $4.25 — $4.71 $10.7B ↑10 ↓0

Cross-Platform Signals

Insider Trades (90d)
4 buys / 0 sells
Institutional
RENAISSANCE TECHNOLOGIES LLC — exit (-100%)
Institutional
NORGES BANK — new
Institutional
NORGES BANK — exit (-100%)
Short Interest
Short: 343,424 | Exempt: 2 | TRF Vol: 592,423 | Short Ratio: 58.0% | Off-exchange volume (dark pool + OTC)

Insider activity strongly supports the bullish upgrade: CEO J. Erik Fyrwald and Chairman Paul J. Fribourg made combined purchases of ~$2M in March 2026. These are large, cluster buys from C-suite, which per academic literature are strongly predictive. Institutional flows show Norges Bank opening a $113M position while Renaissance Technologies fully exited. Short interest is extreme at 58% of float, indicating heavy bearish positioning that could fuel a squeeze on positive news. No congressional trades were recorded. The insider buys and analyst upgrade converge bullish; the extreme short interest is a high-risk, high-reward factor.

Actionable Insight

Traders should view the insider buying and analyst cluster as a strong bullish signal, especially with short interest near 58%. A near-term catalyst (e.g., earnings beat or guidance raise) could trigger a sharp squeeze. Long positions with tight stops are warranted, but watch for near-term EPS revision risk.

Documents Analyzed

Report based on filing metadata.

6 reports for IFF
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+20▲ +7.52%Apr 16, 2026
Filters
Rows
Reports for IFF — sortable, filterable
Type Now
Jun 9, 2026
5d ago
ANALYST-UPGRADE
BULLISH ★ 3/10
$74.65 awaiting T+5awaiting T+5$78.27 (+4.85%)
Jun 1, 2026
13d ago
8-K
BULLISH ★ 7/10
$74.26 $73.01▼ −1.68%▲ +1.07%$78.27 (+5.40%)
May 16, 2026
29d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$82.51 $81.76▼ −0.92%▼ −1.01%$78.27 (−5.14%)
Apr 16, 2026
8w ago
ANALYST-UPGRADE
BULLISH ★ 8/10
$72.06 $70.94▼ −1.55%▼ −2.54%$78.27 (+8.62%)
Mar 18, 2026
12w ago
DEFA14A
NEUTRAL ★ 3/10
$67.91 $70.71▲ +4.12%▲ +4.84%$78.27 (+15.26%)
Mar 12, 2026
13w ago
Insider Cluster
BULLISH ★ 7/10
$69.60 $67.73▼ −2.69%▼ −1.71%$78.27 (+12.46%)
Showing 6 of 6

US Market Status

Market Closed — Opens in 1h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access